“Imagine how many lives could be saved if we spent as much energy on rare disease awareness and education as we do on celebrity culture.” Patient advocacy groups (PAGs) are critical in bridging the ...
Results from the Phase 3 MITIGATE trial of a biologic called inebilizumab have raised hopes the tide may be turning in the hunt for an alternative treatment to steroids for IgG4-related disease ...
Myasthenia gravis is a rare immune-mediated disorder (affecting less than 100,000 patients in the US) in which the immune system mistakenly targets nerves or muscles. Historically, myasthenia gravis ...
“A patient who already has PTSD is going to have a more sensitive nervous system that will be more reactive to the addition of an exogenous stressor such as steroids, creating a medication-based ...
Building on the momentum of its launch, initial results from the Sam (Steroids and Me) platform were excitedly presented in a poster session during the American College of Rheumatology (ACR) Annual ...